Vivos Therapeutics CEO R Huntsman's 2023 pay falls 30% to $658K
Vivos Therapeutics reports 2023 executive compensation
By ExecPay News
Published: October 7, 2024
Vivos Therapeutics reported fiscal year 2023 executive compensation information on October 7, 2024.
In 2023, two executives at Vivos Therapeutics received on average a compensation package of $529K, a 5% increase compared to previous year.
Average pay of disclosed executives at Vivos Therapeutics
R. Kirk Huntsman, Chief Executive Officer, received $658K in total, which decreased by 30% compared to 2022. 70% of Huntsman's compensation, or $463K, was in salary. Huntsman also received $176K of change in pension value and nonqualified deferred compensation earnings and $19K in other compensation.
Bradford Amman, Chief Financial Officer, received a compensation package of $400K, which decreased by 19% compared to previous year. 78% of the compensation package, or $314K, was in salary.
Related executives
You may also like
Source: SEC filing on October 7, 2024.